Stryker Long-Term Investments 2010-2024 | SYK

Stryker long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Stryker long-term investments for the quarter ending September 30, 2024 were $M, a NAN% increase year-over-year.
  • Stryker long-term investments for 2023 were $0B, a NAN% decline from 2022.
  • Stryker long-term investments for 2022 were $0B, a NAN% decline from 2021.
  • Stryker long-term investments for 2021 were $0B, a NAN% decline from 2020.
Stryker Annual Long-Term Investments
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Stryker Quarterly Long-Term Investments
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $139.868B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.059B 26.03
Boston Scientific (BSX) United States $124.863B 35.90
Medtronic (MDT) Ireland $114.537B 17.04
EssilorLuxottica (ESLOY) France $110.799B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.365B 0.00
Haleon (HLN) United Kingdom $44.180B 28.71
GE HealthCare Technologies (GEHC) United States $39.743B 20.61
ResMed (RMD) United States $35.761B 29.39
Terumo (TRUMY) Japan $28.532B 40.29
Koninklijke Philips (PHG) Netherlands $25.454B 19.48
Zimmer Biomet Holdings (ZBH) United States $21.582B 13.74
Baxter (BAX) United States $18.264B 12.39
Insulet (PODD) United States $16.648B 70.04
Smith & Nephew SNATS (SNN) United Kingdom $11.052B 0.00
Bio-Rad Laboratories (BIO) United States $10.282B 35.10
BellRing Brands (BRBR) United States $8.726B 36.90
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $8.016B 19.24
ICU Medical (ICUI) United States $4.201B 40.09
TG Therapeutics (TGTX) United States $3.771B 0.00
Haemonetics (HAE) United States $3.763B 18.61
Envista Holdings (NVST) United States $3.662B 27.28
Prestige Consumer Healthcare (PBH) United States $3.657B 18.22
Perrigo (PRGO) Ireland $3.466B 10.95
Neogen (NEOG) United States $3.127B 36.08
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.988B 18.00
QuidelOrtho (QDEL) United States $2.628B 16.56
Agios Pharmaceuticals (AGIO) United States $2.557B 0.00
Green Thumb Industries (GTBIF) United States $2.260B 38.14
LeMaitre Vascular (LMAT) United States $2.165B 52.65
Curaleaf Holdings (CURLF) Canada $2.023B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.960B 0.00
Warby Parker (WRBY) United States $1.769B 0.00
AtriCure (ATRC) United States $1.641B 0.00
InMode (INMD) Israel $1.460B 8.78
AdaptHealth (AHCO) United States $1.365B 9.85
Verano Holdings (VRNOF) United States $1.231B 0.00
BioLife Solutions (BLFS) United States $1.179B 0.00
Evolus (EOLS) United States $1.036B 0.00
Owens & Minor (OMI) United States $0.925B 7.23
National Vision Holdings (EYE) United States $0.915B 29.08
Phibro Animal Health (PAHC) United States $0.906B 18.80
CeriBell (CBLL) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.844B 0.00
Cresco Labs (CRLBF) United States $0.747B 0.00
VAREX IMAGING (VREX) United States $0.542B 16.36
Surmodics (SRDX) United States $0.536B 113.85
Quanterix (QTRX) United States $0.532B 0.00
Canopy Growth (CGC) Canada $0.515B 0.00
Valneva SE (VALN) France $0.475B 0.00
ZimVie (ZIMV) United States $0.398B 33.56
Viemed Healthcare (VMD) United States $0.331B 35.54
Aurora Cannabis (ACB) Canada $0.328B 0.00
OraSure Technologies (OSUR) United States $0.315B 8.12
TerrAscend (TSNDF) Canada $0.309B 0.00
Jin Medical (ZJYL) China $0.308B 0.00
Sanara MedTech (SMTI) United States $0.293B 0.00
Cerus (CERS) United States $0.290B 0.00
Biote (BTMD) United States $0.280B 12.93
Ayr Wellness (AYRWF) United States $0.279B 0.00
Zynex (ZYXI) United States $0.255B 53.33
Omeros (OMER) United States $0.246B 0.00
High Tide (HITI) Canada $0.234B 97.00
MacroGenics (MGNX) United States $0.232B 0.00
Utah Medical Products (UTMD) United States $0.225B 15.14
Organigram Holdings (OGI) Canada $0.195B 0.00
Brainsway (BWAY) Israel $0.172B 206.40
FitLife Brands (FTLF) United States $0.145B 19.54
Rockwell Medical (RMTI) United States $0.121B 0.00
TriSalus Life Sciences (TLSI) United States $0.117B 0.00
Quipt Home Medical (QIPT) United States $0.113B 0.00
Veru (VERU) United States $0.107B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 23.90
Fonar (FONR) United States $0.092B 9.51
Jushi Holdings (JUSHF) United States $0.092B 0.00
Cellectar Biosciences (CLRB) United States $0.082B 0.00
Zevia PBC (ZVIA) United States $0.079B 0.00
InterCure (INCR) Israel $0.079B 0.00
Modular Medical (MODD) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Sanuwave Health (SNWVD) United States $0.064B 1.63
MariMed (MRMD) United States $0.062B 0.00
Cytosorbents (CTSO) United States $0.047B 0.00
Allurion Technologies (ALUR) United States $0.045B 0.00
Exagen (XGN) United States $0.043B 0.00
Apyx Medical (APYX) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Nephros (NEPH) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GlucoTrack (GCTK) United States $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 17.87
SNDL (SNDL) Canada $0.000B 0.00